Original Publication Date: 1 January, 2016
Publication / Source: Future Oncology
Authors: Craig Erker, Paul Harker-Murray & Michael J Burke
Hodgkin and non-Hodgkin lymphoma collectively are the third most common cancer diagnosed in children each year. For children who relapse or have refractory disease, outcomes remain poor. Immunotherapy has recently emerged as a novel approach to treat hematologic malignancies.